“alder-biopharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Senate Drama, A.I. Stories, Data Dives, Shkreli & More 06/30/17 National
Alder Drug Cuts Down Migraines in Study, But Still Trails Rivals 06/27/17 Seattle
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results 05/31/17 New York
Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing 05/12/17 Indiana
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Keeping Lead in Migraine Drug Race, Amgen Touts Data, Preps FDA Filing 11/16/16 San Francisco
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
In Race to Relief, Amgen Touts New But Incomplete Migraine Data 06/09/16 San Francisco
With New Data, Alder Keeps Pace in Migraine Drug Race 03/28/16 Seattle
West Coast Biotech Roundup: Orexigen, Denali, Nant, ASCO & More 05/15/15 San Diego
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
Bristol-Myers Kicks Arthritis Drug Back to Alder, Shares Tumble 09/02/14 Seattle
Radius Health Yanks IPO, Cites Market Conditions 05/09/14 Boston
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
Biotech IPO Slump Deepens as Alder Prices Below Range 05/08/14 Seattle
Alder Biopharmaceuticals Lands $80,000,000 New Funding Round 05/08/14 Seattle
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M 03/19/14 Seattle
Bristol-Myers, Alder Drug for Rheumatoid Arthritis Passes Key Test 10/28/13 Seattle
Who Should Biotech Pros Follow on Twitter? An Update for 2013 08/19/13 National
LSINW Roundup: Alder, Omeros, Adaptive and Women to Watch 07/11/13 Seattle
Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections 05/22/13 Seattle
See Clay Siegall, Kim Popovits, Mitch Gold This Afternoon 04/09/13 Seattle
Biotech for the Belt-Tightening Era: Last Chance For Early-Bird Tix 03/12/13 Seattle
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
Alder Gets $3.5M Milestone as Bristol-Myers Starts Crohn’s Study 08/27/12 Seattle
Alder Biopharma Snags $38M To Charge Ahead With Antibody Drugs 04/19/12 Seattle
Alder Biopharmaceuticals Receives $38,000,000 Series D Financing Round 04/19/12 Seattle
Page 1 of 3 next page »